Prothena Corp Public (PRTA) Asset Utilization Ratio (2013 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Asset Utilization Ratio of 0.17 in Q1 2026, up 500.72% quarter-over-quarter from 0.03 in Q4 2025, and down 35.29% on a YoY basis from 0.26 in Q1 2025.
Prothena Corp Public (PRTA) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Prothena Corp Public's Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.17 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 35.29% year-over-year to 0.17; the TTM figure through Mar 2026 stood at 0.17 (down 35.29% YoY), while the FY2025 annual figure was 0.02, down 89.8% from the prior year.
- Asset Utilization Ratio was 0.17 for Q1 2026 at Prothena Corp Public, up from 0.03 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.34 in Q2 2024 to a low of 0.01 in Q3 2022.
- Historically, Asset Utilization Ratio has averaged 0.15 across 5 years, with a median of 0.14 in 2024.
- Biggest YoY gain for Asset Utilization Ratio was 13735.08% in 2022; the steepest drop was 97.5% in 2022.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.08 in 2022, then surged by 54.14% to 0.13 in 2023, then soared by 86.89% to 0.24 in 2024, then plunged by 87.95% to 0.03 in 2025, then jumped by 500.72% to 0.17 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.17 (Q1 2026), 0.03 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.17 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.21 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.37 |
| Jun 30, 2021 | 0.15 |